EUVIMEDEUVIMED entdecken
Crossref

Discovery of High-Affinity SMARCA2/4 Bromodomain Ligands and Development of Potent and Exceptionally Selective SMARCA2 PROTAC Degraders

Lingying Leng, Wenbin Tu, Lin Yang, Liyue Huang, Mi Wang, Jennifer L Meagher, Krishnapriya Chinnaswamy, Srinivasa Rao Allu, Rohan Kalyan Rej iD, Jelena Tošović iD, Lalgudi Harikrishnan, Zhenwu Li iD und 3 weitere

Journal of Medicinal Chemistry · 2025

DOI: 10.1021/acs.jmedchem.4c01903 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2025. Verfasst von Lingying Leng und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, United States. Hauptthemen laut MEDLINE: Transcription Factors, Nuclear Proteins. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 54 Literaturangaben. Gefördert von: NCI NIH HHS, National Cancer Institute, Oncopia Therapeutics, Inc..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the SWI/SNF chromatin-remodeling complex, the mutually exclusive catalytic ATPase subunits SMARCA2 and SMARCA4 proteins have a synthetic-lethal relationship. Selectively targeting SMARCA2 for degradation is a promising and new therapeutic strategy for human cancers harboring inactivated mutated SMARCA4. In this study, we report the design, synthesis, and biological evaluation of novel SMARCA2/4 ligands and our subsequent design of PROTAC degraders using high-affinity SMARCA ligands and VHL-1 ligands. Our efforts led to the discovery of high-affinity SMARCA2/4 bromodomain ligands and the development of a potent and selective SMARCA2 degrader and a highly potent SMARCA2/4 and PBRM1 degrader.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcription FactorsNuclear ProteinsHumansLigandsProteolysisDrug DiscoveryStructure-Activity RelationshipDNA HelicasesDNA-Binding Proteins

Substanzen

Transcription FactorsLigandsSMARCA2 protein, humanNuclear ProteinsDNA HelicasesSMARCA4 protein, humanDNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan 48109, United States.
  • Department of Medicinal Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States.
  • Life Sciences Institute, University of Michigan, Ann Arbor, Michigan 48109, United States.
  • SK Life Science Laboratories, 2500 Renaissance Blvd, King of Prussia, Pennsylvania 19406, United States.
  • Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan 48109, United States.
  • Department of Pharmacology, University of Michigan, Ann Arbor, Michigan 48109, United States.

ORCID-Profile: Rohan Kalyan Rej, Jelena Tošović, Zhenwu Li, Shaomeng Wang

Förderung

  • NCI NIH HHS
  • National Cancer Institute
  • Oncopia Therapeutics, Inc.

Zitieren

APA

Leng, L., Tu, W., Yang, L., Huang, L., Wang, M., Meagher, J. L., Chinnaswamy, K., Allu, S. R., Rej, R. K., Tošović, J., Harikrishnan, L., Li, Z., Sui, Z., Stuckey, J. A., & Wang, S. (2025). Discovery of High-Affinity SMARCA2/4 Bromodomain Ligands and Development of Potent and Exceptionally Selective SMARCA2 PROTAC Degraders. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.4c01903

Vancouver

Leng L, Tu W, Yang L, Huang L, Wang M, Meagher JL, et al. Discovery of High-Affinity SMARCA2/4 Bromodomain Ligands and Development of Potent and Exceptionally Selective SMARCA2 PROTAC Degraders. Journal of Medicinal Chemistry. 2025. doi:10.1021/acs.jmedchem.4c01903

BibTeX
@article{Leng2025,
  author = {Leng, Lingying and Tu, Wenbin and Yang, Lin and Huang, Liyue and Wang, Mi and Meagher, Jennifer L and Chinnaswamy, Krishnapriya and Allu, Srinivasa Rao and Rej, Rohan Kalyan and Tošović, Jelena and Harikrishnan, Lalgudi and Li, Zhenwu and Sui, Zhihua and Stuckey, Jeanne A and Wang, Shaomeng},
  title = {Discovery of High-Affinity SMARCA2/4 Bromodomain Ligands and Development of Potent and Exceptionally Selective SMARCA2 PROTAC Degraders},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  doi = {10.1021/acs.jmedchem.4c01903}
}
Kostenlos starten →